Noninvasive magnetic resonance imaging evaluation of cerebral blood flow with acetazolamide challenge in patients with cerebrovascular stenosis

Journal of Magnetic Resonance Imaging

Volumn 10, Issue 5, 1999, Pages 870-875

  Detre, John A ^a   Samuels, Owen B ^a   Alsop, David C ^a   Gonzalez At, Julio B ^a   Kasner, Scott E ^a   Raps, Eric C ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acetazolamide; Cerebral blood flow; Cerebrovascular disease; Ischemia; Magnetic resonance imaging

Indexed keywords

ACETAZOLAMIDE;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; DEMOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE CEREBRAL ARTERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL;

ACETAZOLAMIDE; ADOLESCENT; AGED; AGED, 80 AND OVER; CAROTID STENOSIS; CEREBRAL ARTERIAL DISEASES; CEREBROVASCULAR CIRCULATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 0032734837     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199911)10:5<870::AID-JMRI36>3.0.CO;2-D     Document Type: Article

References (31)

1. Blakeley DD, Oddone EZ, Hasselblad V, Simel DL, Matchar DB. Noninvasive carotid artery testing. A meta-analytic review. Ann Int Med 1995;122:360-367.
2. Dagirmanjlan A, Ross JS, Obuchowskl N, et al. High resolution, magnetization transfer saturation, variable flip angle, time-of-flight MRA in the detection of intracranial vascular stenoses. J Comp Assist Tomogr 1995;19:700-706.
3. Turnipseed WD, Kennell TW, Turski PA, Acher CW, Hoch JR. Combined use of duplex imaging and magnetic resonance angiography for evaluation of patients with symptomatic ipsilateral high-grade carotid stenosis. J Vasc Surg 1993;17:832-839.
4. Rosen BR, Belliveau JW, Chien D. Perfusion imaging by nuclear magnetic resonance. Magn Reson Q 1989;5:263-281.
5. Detre JA, Zhang W, Roberts DA, et al. Tissue specific perfusion imaging using arterial spin labeling. NMR Biomed 1994;7:75-82.
6. Edelman RR, Siewert B, Darby DG, et al. Qualitative mapping of cerebral blood flow and functional localization with echo-planar MR Imaging and signal targeting with alternating radio frequency. Radiology 1994;192:513-520.
7. Wong EC, Buxton RB, Frank LR. A theoretical and experimental comparison of continuous and pulsed arterial spin labeling techniques for quantitative perfusion imaging. Magn Reson Med 1998; 40:348-355.
8. Alsop DC, Detre JA. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metabol 1996;16:1236-1249.
9. Alsop DC, Detre JA. Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology 1998;208:410-416.
10. Walsh EG, Minematsu K, Leppo J, Moore SC. Radioactive microsphere validation of a volume localized continuous saturation perfusion measurement. Magn Reson Med 1993;31:147-153.
11. 15O PET validation of arterial spin tagging measurements of cerebral blood flow in humans [abstract]. Proc Intl Magn Reson Med 1997;5:87.
12. Lassen NA. Control of cerebral circulation in health and disease. Circ Res 1974;34:749-760.
13. Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol 1991;29:231-240.
14. Kuroda S, Kamiyama H, Abe H, Houkin K, Isobe M, Mitsumori K. Acetazolamide test in detecting reduced cerebral perfusion reserve and predicting long-term prognosis in patients with internal carotid artery occlusion. Neurosurgery 1993;32:912-918.
15. Gur AY, Bova I, Bornstein NM. Is impaired cerebral vasomotor reactivity a predictive factor of stroke in asymptomatic patients? Stroke 1996;27:2188-2190.
16. Webster MW, Makaroun MS, Steed DL, Smith HA, Johnson DW, Yonas H. Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease. J Vasc Surg 1995;21:338-344.
17. Yokota C, Hasegawa Y, Minematsu K, Yamaguchi T. Effect of acetazolamide reactivity and long-term outcome in patients with major cerebral artery occlusive diseases. Stroke 1998;29:640-644.
18. Isaka Y, Okamoto M, Ashida K, Imaizumi M. Decreased cerebrovascular dilatory capacity in subjects with asymptomatic periventricular hyperintensities. Stroke 1994;25:375-381.
19. Detre JA, Alsop DC, Vives LR, Maccotta L, Teener JW, Raps EC. Noninvasive MRI evaluation of cerebral blood flow in cerebrovascular disease. Neurology 1998;50:633-641.
20. Alsop DC. Correction of ghost artifacts and distortion in echoplanar MR imaging with an iterative reconstruction technique [abstract]. Radiology 1995;197P:388.
21. Alsop DC, Detre JA. Reduction of excess noise in fMRI time series data using noise image templates [abstract]. Proc Intl Magn Reson Med 1997;5:1687.
22. Matsui T, Hirano A. An atlas of the human brain for computerized tomography. Tokyo: Igaku-Shoin; 1978.
23. Moody DM, Bell MA, Challa VR. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. AJNR 1990;11:431-439.
24. de Reuck J. The human periventricular arterial blood supply and the anatomy of cerebral infarctions. Eur Neurol 1971;5:321-334.
25. Weiller C, Ringelstein E, Reiche W, Buell U. Clinical and hemodynamic aspects of low-flow infarcts. Stroke 1991;22:1117-1123.
26. Fisher M, McQuillen JB. Bilateral cortical borderzone infarction: a pseudobrainstem stroke. Arch Neurol 1981;38:62-63.
27. Guckel FJ, Brix G, Schmiedek P, et al. Cerebrovascular reserve capacity in patients with occlusive cerebrovascular disease: assessment with dynamic susceptibility contrast-enhanced MR imaging and the acetazolamide stimulation test. Radiology 1996;201:405-412.
28. Strandgaard S, Paulson OB. Pathophysiology of stroke. J Cardiovasc Pharmacol 1990;15:S38-S42.
29. 15O]H2O positron emission tomography. Stroke 1995;26:1825-1829.
30. Smith HA, Thompson-Dobkin J, Yonas H, Flint E. Correlation of xenon-enhanced computed tomography-defined cerebral blood flow reactivity and collateral flow patterns. Stroke 1994;25:1784-1787.
31. Barnett HJM. Hemodynamic cerebral ischemia: an appeal for systematic data gathering prior to a new EC/IC trial. Stroke 1997;28:1857-1860.